Tech Company Financing Transactions
TransMedics Funding Round
3i Venture Capital, Alta Partners and VantagePoint Capital Partners participated in a $29.8 million Series C funding round for TransMedics. The round was announced by the company on 3/14/2006.
Transaction Overview
Company Name
Announced On
3/14/2006
Transaction Type
Venture Equity
Amount
$29,750,000
Round
Series C
Investors
Proceeds Purpose
The capital will be used to accelerate TransMedics' growth by continuing the PROTECT trial, and initiating new trials in Europe and the U.S. Additionally, it will be used for commercialization of the Organ Care System, and to extend the platform to other organs beyond the heart, such as the lung, liver and kidneys.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
200 Minuteman Rd. 302
Andover, MA 01810
USA
Andover, MA 01810
USA
Phone
Website
Email Address
Overview
TransMedics (Nasdaq: TMDX) has developed a revolutionary new system that enables living organ transplants.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Waleed Hassanein
Chief Financial Officer
Stephen Gordon
Chief Medical Officer
Tamer Khayal
Vice President
Jacqueline Sneve
VP - Engineering
John Sullivan
VP - Operations
John Carey
VP - Regulatory Affairs
Miriam Provost
Browse more venture capital transactions:
Prev: 3/14/2006: Metaweb Technologies venture capital transaction
Next: 3/14/2006: Everypoint venture capital transaction
Share this article
About Database of VC Transactions
We document tech company VC transactions. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs